deoxyarbutin

reversible tyrosinase inhibitor with effective in vivo skin lightening potency; structure in first source

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Hypopigmentation (Hypomelanosis) 05/03/2017 - "Arbutin (Arb) and deoxyArbutin (dA) are both effective hypopigmentation agents. " 05/03/2017 - "Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin."
2.	Hyperpigmentation 12/03/2021 - "The results demonstrated that the developed microemulsion encapsulating dA may allow the use of deoxyArbutin instead of hydroquinone to treat dermal hyperpigmentation disorders in the future."
3.	Pancreatitis 09/01/2022 - "Deoxyarbutin attenuates severe acute pancreatitis via the HtrA2/PGC-1α pathway."
4.	Melanoma (Melanoma, Malignant) 01/01/2017 - "Deoxyarbutin displays antitumour activity against melanoma in vitro and in vivo through a p38-mediated mitochondria associated apoptotic pathway."